Inflammatory markers are used in the assessment of cancer and other chronic diseases. Inflammation markers raise in the inflammatory conditions. C reactive protein and interleukin are the most common form of inflammatory markers.
Some of the common inflammatory conditions include rheumatoid arthritis, tissue injury and burns, Crohn's disease, cancer, etc.
Introduction of an infectious organism including mycobacterium tuberculosis, protozoa, fungi, and other parasites that can resist host defenses and remain in the tissue for an extended period, is one of the major cause of chronic inflammation.
Other causes of chronic inflammation include exposure to a low level of particular irritant and foreign particles, autoimmune diseases, in which the immune system is sensitized. Chronic inflammation can be caused due to repeated episodes of acute inflammation.
Increasing prevalence of cancer is one of the major factors, responsible for the significant growth of inflammatory markers market. Increasing population especially in developing regions and increasing prevalence of other chronic diseases, is expected to increase the growth of inflammatory markers market. Increasing research and developmental activities is another important factor which can drive the growth of inflammatory markers market.
Other factors such as increasing healthcare awareness, an increasing number of hospitals and research laboratories, etc. are expected to increase the growth of inflammatory markers market. Increasing government initiatives and increasing government funding for the research activities, is a very important factor which can increase the growth of inflammatory markers market.
An increasing number of diagnostic laboratories is expected to increase the growth of global inflammation markers market.
There are a few factors, which can restrain the growth of inflammatory markers market. Lack of healthcare awareness in some of the emerging regions is expected to increase the growth of the global inflammatory markers market.
Based on product type, inflammatory markers market has been segmented into interlukins, C reactive proteins, lepitine, cellular adhesion molecules, tumor necrosis factors and others. Interlukins are expected to hold a large revenue share in the global inflammatory markers market.
Based on the indications, the global inflammatory markers market has been segmented into tumors, arthritis, multiple sclerosis, diabetes and various other applications. Tumors are expected to hold a large revenue share in the overall inflammatory markers market.
Based on the end user, the inflammatory markers market has been segmented into hospitals, clinics, research laboratories and others. Research laboratories are expected to hold a significant share in the global inflammatory markers market.
On the basis of geography, global inflammatory markers market is segmented into several key regions viz. North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East and Africa. North America is expected to hold the largest shares in the inflammatory markers market primarily due to presence of well-established healthcare infrastructure and the presence of large number of research laboratories Europe is expected to hold a large revenue share in Inflammatory markers market due to increasing population and increasing prevalence of chronic diseases.
Asian countries are also expected to hold a significant growth rate in the forecast period due to increasing healthcare awareness among the people.
There are many companies manufacturing inflammatory markers. Some of the key players present in Global Inflammatory markers market are Merck and Co., Novartis International AG, Abnova, Cayman Chemical, Thermo Fisher Scientific, Cell Signaling Technology, Inc., Boditech Med Inc., LSI Medience Corporation, Abbott Diagnostics Inc., Siemens Healthcare Diagnostics Inc., BG Medicine Inc., LifeSign LLC.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Global Inflammatory markers is segmented by product type, indication and end user:
Segmentation by Product Type
Segmentation by Indications
Segmentation by End Users
Our Research Products
The "Full Research Suite" delivers actionable market intel, deep dives on markets or technologies, so clients act faster, cut risk, and unlock growth.
The Leaderboard benchmarks and ranks top vendors, classifying them as Established Leaders, Leading Challengers, or Disruptors & Challengers.
Locates where complements amplify value and substitutes erode it, forecasting net impact by horizon
We deliver granular, decision-grade intel: market sizing, 5-year forecasts, pricing, adoption, usage, revenue, and operational KPIs—plus competitor tracking, regulation, and value chains—across 60 countries broadly.
Spot the shifts before they hit your P&L. We track inflection points, adoption curves, pricing moves, and ecosystem plays to show where demand is heading, why it is changing, and what to do next across high-growth markets and disruptive tech
Real-time reads of user behavior. We track shifting priorities, perceptions of today’s and next-gen services, and provider experience, then pace how fast tech moves from trial to adoption, blending buyer, consumer, and channel inputs with social signals (#WhySwitch, #UX).
Partner with our analyst team to build a custom report designed around your business priorities. From analysing market trends to assessing competitors or crafting bespoke datasets, we tailor insights to your needs.
Supplier Intelligence
Discovery & Profiling
Capacity & Footprint
Performance & Risk
Compliance & Governance
Commercial Readiness
Who Supplies Whom
Scorecards & Shortlists
Playbooks & Docs
Category Intelligence
Definition & Scope
Demand & Use Cases
Cost Drivers
Market Structure
Supply Chain Map
Trade & Policy
Operating Norms
Deliverables
Buyer Intelligence
Account Basics
Spend & Scope
Procurement Model
Vendor Requirements
Terms & Policies
Entry Strategy
Pain Points & Triggers
Outputs
Pricing Analysis
Benchmarks
Trends
Should-Cost
Indexation
Landed Cost
Commercial Terms
Deliverables
Brand Analysis
Positioning & Value Prop
Share & Presence
Customer Evidence
Go-to-Market
Digital & Reputation
Compliance & Trust
KPIs & Gaps
Outputs
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Inflammatory Diseases Market Size and Share Forecast Outlook 2025 to 2035
Inflammatory Bowel Disease Treatment Market Size and Share Forecast Outlook 2025 to 2035
Anti-Inflammatory Skincare Products Market Size and Share Forecast Outlook 2025 to 2035
Rare Inflammatory Disease Treatment Market Size and Share Forecast Outlook 2025 to 2035
Breaking Down Market Share in Anti-Inflammatory Biologics
EPO Biomarkers Market Size and Share Forecast Outlook 2025 to 2035
Pelvic Inflammatory Disease Therapeutics Market
Hepatic Markers Market Size and Share Forecast Outlook 2025 to 2035
Utility Markers Market Size and Share Forecast Outlook 2025 to 2035
Imaging Markers Market Analysis - Size, Share, and Forecast Outlook 2025 to 2035
Diabetic Markers Market Size and Share Forecast Outlook 2025 to 2035
Fiducial Markers Market - Demand, Growth & Forecast 2025 to 2035
Vitamin Biomarkers Market Size and Share Forecast Outlook 2025 to 2035
Electrolyte Markers Market Size and Share Forecast Outlook 2025 to 2035
Coagulation Markers Market Trends - Growth, Demand & Forecast 2025 to 2035
Cell Surface Markers Detection Market Size and Share Forecast Outlook 2025 to 2035
Molecular Biomarkers For Cancer Detection Market Size and Share Forecast Outlook 2025 to 2035
Chronic Phase Markers Market Size and Share Forecast Outlook 2025 to 2035
Prognostic Biomarkers Market
Neurological Biomarkers Market Size and Share Forecast Outlook 2025 to 2035
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA